Sabra Health Care REIT, Inc. (SBRA)
After hours:
| Previous close | 13.60 |
| Open | 13.71 |
| Bid | 13.46 x 200 |
| Ask | 13.48 x 400 |
| Day's range | 13.46 - 13.72 |
| 52-week range | 10.30 - 14.91 |
| Volume | |
| Avg. volume | 2,074,083 |
| Market cap | 3.116B |
| Beta (5Y monthly) | 1.17 |
| PE ratio (TTM) | 224.33 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.20 (8.92%) |
| Ex-dividend date | 12 Feb 2024 |
| 1y target est | N/A |
- Business Wire
Sabra Reports Fourth Quarter 2023 Results; Introduces 2024 Guidance
TUSTIN, Calif., February 27, 2024--Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2023.
- Business Wire
Sabra Health Care REIT, Inc. to Attend Citi’s 2024 Global Property CEO Conference and the 2024 NIC Spring Conference
TUSTIN, Calif., February 20, 2024--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company’s Chair and Chief Executive Officer, Michael Costa, the company’s Chief Financial Officer, and Lukas Hartwich, the company’s Senior Vice President of Finance, will attend Citi’s 2024 Global Property CEO Conference on March 4-6, 2024, at The Diplomat Beach Resort in Hollywood, Florida.
- Business Wire
Sabra Health Care REIT, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call; Declares Common Dividend
IRVINE, Calif., February 01, 2024--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2023 fourth quarter earnings release on February 27, 2024, after the close of trading.
